Definition / meaning of CP-358,774

A drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. CP-358,774 is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called erlotinib, erlotinib hydrochloride, OSI-774, and Tarceva.

Listed under:

Find More About 'CP-358,774'


The Web site of the National Cancer Institute (http://www.cancer.gov/)

Leave a Comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.